HYBRID EVENT: You can participate in person at London, UK or Virtually from your home or work.

5th Edition of Euro-Global Conference on Biotechnology and Bioengineering

September 18-20 | Hybrid Event

September 18-20, 2025 | London, UK

Commercialization & Investment in Biotechnology

Commercialization & Investment in Biotechnology

Commercialization & investment in biotechnology are key forces transforming laboratory discoveries into real-world applications that benefit health, industry, and the environment. This domain bridges the gap between research innovation and market readiness, involving intellectual property strategies, regulatory navigation, and business model development. Investors, venture capitalists, and corporate partners play a crucial role in funding early-stage biotech startups, clinical trials, and manufacturing scale-up. Commercialization & Investment in Biotechnology also include public-private partnerships and technology transfer offices that support licensing and entrepreneurship. As competition intensifies, strategic alliances and investor confidence hinge on strong scientific validation, scalable platforms, and clear regulatory pathways. This process not only accelerates product development but ensures that scientific breakthroughs reach patients, consumers, and industries worldwide.

Committee Members
Speaker at Biotechnology and Bioengineering 2025 - Anand Srivastava

Anand Srivastava

Global Institute of Stem Cell Therapy and Research, United States
Speaker at Biotechnology and Bioengineering 2025 - Michele Mishto

Michele Mishto

Francis Crick Institute, United Kingdom
Speaker at Biotechnology and Bioengineering 2025 - Thomas J Webster

Thomas J Webster

Brown University, United States
ECBB 2025 Speakers
Speaker at Biotechnology and Bioengineering 2025 - Yan Xiaojun

Yan Xiaojun

CytoNiche Biotech Pte. Ltd, Singapore
Speaker at Biotechnology and Bioengineering 2025 - Assad Alammar

Assad Alammar

Specialty Enzymes and Probiotics, United States
Speaker at Biotechnology and Bioengineering 2025 - Tina Moller Tagmose

Tina Moller Tagmose

Novo Nordisk A/S, Denmark
Speaker at Biotechnology and Bioengineering 2025 - Yin Ying Ho

Yin Ying Ho

Agency for Science, Technology and Research (A*STAR), Singapore
Tags

Submit your abstract Today

Watsapp
a